Early Efficacy of Ferric Carboxymaltose (Ferinject®) in Patients with Iron-Deficiency Anemia: Single Institution Experience

被引：0
|
作者：
Kerbage, Fouad [1 ,2 ,3 ]
Sakr, Riwa [2 ,3 ]
Akoury, Elie [2 ,3 ]
Eid, Anthony [2 ,3 ]
Chahine, Georges [2 ,3 ]
Massoud, Marcel [2 ,3 ]
机构：
[1] Inst Gustave Roussy, Hematol Dept, Villejuif, France
[2] Holy Spirit Univ Kaslik, Jounieh, Lebanon
[3] UHC Notre Dame Secours, Jbeil, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
Ferric Carboxymaltose; Early Efficacy; Iron Deficiency Anemia;
D O I：
10.1016/j.clml.2018.07.245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-056
引用
下载
收藏
页码：S296 / S297
页数：2
相关论文
共 50 条
  • [21] Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron
    Gary R. Lichtenstein
    Jane E. Onken
    Digestive Diseases and Sciences, 2018, 63 : 3009 - 3019
  • [22] Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bailie, George R.
    Mason, Nancy A.
    Valaoras, Thomas G.
    HEMODIALYSIS INTERNATIONAL, 2010, 14 (01) : 47 - 54
  • [23] Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience
    Secilmis, S.
    Iskender, D.
    Candir, B. A.
    Bozan, E.
    Yaman, S.
    Ulu, B. U.
    Yigenoglu, T. N.
    Cakar, M. K.
    Dal, M. S.
    Altuntas, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (10) : 3487 - 3492
  • [24] Efficacy and tolerability of ferric carboxymaltose for treating moderate iron deficiency anemia of the postpartum
    Bolandard, F.
    Gaman, O.
    Alibaud, R.
    Soulas, S.
    Metais, C.
    Bordarier, M.
    Jacob, A.
    Hochart, D.
    Ciocanel, O.
    El Hachem, R.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2013, 32 : A367 - A368
  • [25] Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study
    Katsuya Ikuta
    Hiroaki Ito
    Keiji Takahashi
    Shinya Masaki
    Masaru Terauchi
    Yasuo Suzuki
    International Journal of Hematology, 2019, 109 : 50 - 58
  • [26] Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study
    Ikuta, Katsuya
    Ito, Hiroaki
    Takahashi, Keiji
    Masaki, Shinya
    Terauchi, Masaru
    Suzuki, Yasuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 50 - 58
  • [27] Efficacy and acceptability of a single dose of ferric carboxymaltose (Ferinject®) on anaemia in a pregnant population
    Brown, A.
    Marsden, P.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 28 - 29
  • [28] Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications
    Bailie, George R.
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2010, 60 (6A): : 386 - 398
  • [29] Ferric Carboxymaltose in the Treatment of Iron-Deficiency Anaemia in Paediatric Patients with Anastomotic Ulcers
    Udina, Chiara
    Lanzetta, Maria Andrea
    Celsi, Fulvio
    Barbi, Egidio
    Gortani, Giulia
    Bramuzzo, Matteo
    Di Leo, Grazia
    CHILDREN-BASEL, 2022, 9 (03):
  • [30] A SINGLE INFUSION OF FERRIC CARBOXYMALTOSE EFFECTIVELY IMPROVES IRON-DEFICIENCY ANEMIA IN PATIENTS WITH GASTROINTESTINAL AND LIVER DISEASE: A HOSPITAL-BASED SURVEY
    Viola, A.
    Cappello, M.
    Cilluffo, M. G.
    Mendolaro, M.
    Craxi, A.
    Almasio, P. L.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E130 - E130
12345